We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolic Syndrome and Inflammatory Markers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00433082
First Posted: February 9, 2007
Last Update Posted: February 9, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Free Islamic University of Medical Sciences
February 8, 2007
February 9, 2007
February 9, 2007
August 2006
Not Provided
Measuring inflammatory markers in metabolic syndrome
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Metabolic Syndrome and Inflammatory Markers
Effect of Fasting With Two Meals on Inflammatory Markers of Metabolic Syndrome
The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Metabolic Syndrome
Behavioral: Ramadan Fasting
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
November 2006
Not Provided

Inclusion Criteria:

  • Males with metabolic syndrome

Exclusion Criteria:

  • Conditions with insulin resistance including;
  • Type 2 diabetes mellitus,
  • Infections,
  • Stresses,
  • Uremia,
  • Acromegaly,
  • Glucocorticoid excess,
  • Hypertension ,
  • Cirrhosis and
  • Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.
Sexes Eligible for Study: Male
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00433082
1345104
Not Provided
Not Provided
Not Provided
Not Provided
Free Islamic University of Medical Sciences
Not Provided
Principal Investigator: Zahra Vahdat Shariatpanahi, MD Islamic Free University of Medical Science
Free Islamic University of Medical Sciences
February 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
To Top